FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

2951011000001106: Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2157841000001114 Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2157851000001112 Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
25925501000001118 Supralip 160mg modified-release tablets (Fournier Pharmaceuticals Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25925601000001119 Supralip 160mg modified-release tablets (Fournier Pharmaceuticals Ltd) 28 tablet 4 x 7 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38122801000001116 Supralip 160mg tablets (Solvay Healthcare Ltd) 28 tablet 4 x 7 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
41067801000001111 Supralip 160mg tablets (Fournier Pharmaceuticals Ltd) 28 tablet 4 x 7 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
42826001000001111 Supralip 160mg tablets (Solvay Healthcare Ltd) 28 tablet 4 x 7 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
63682201000001115 Supralip 160mg tablets (Abbott Healthcare Products Ltd) 28 tablet 4 x 7 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
90070401000001115 Supralip 160mg tablets (BGP Products Ltd) 28 tablet 4 x 7 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
102360101000001110 Supralip 160mg tablets (Mylan Ltd) 28 tablet 4 x 7 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
105620201000001118 Supralip 160mg tablets (Mylan) 28 tablet 4 x 7 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Is a Fenofibrate micronised 160mg modified-release tablets 28 tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Is pack of Supralip 160mg tablets (Viatris UK Healthcare Ltd) false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Has active ingredient Fenofibrate micronized false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Has AMP Supralip 160mg tablets (Viatris UK Healthcare Ltd) true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Fenofibrate micronized true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start